Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Schackman

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|April 7, 2007
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppressionRoy M Gulick, Christina M Lalama, Heather J Ribaudo, et al.
AIDS and Behavior|August 23, 2025
FANMI ("My Family"): A Randomized Trial of Community Cohort Care for Adolescent Girls and Young Women Living with HIV in HaitiVanessa Rouzier, Lindsey K Reif, Rose Cardelle Riche, et al.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
AIDS and Behavior|August 18, 2025
Comparing Implementation and Effectiveness Outcomes for Two Implementation Strategies of the Keep It Up! Digital HIV Prevention Program: A Type 3 Hybrid Effectiveness-Implementation TrialBrian Mustanski, Nanette Benbow, Kathryn Macapagal, et al.
Drug and Alcohol Dependence|January 18, 2022
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugsSarah Gutkind, Laura E Starbird, Sean M Murphy, et al.
Plos One|May 31, 2019
Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesisEmanuel Krebs, Benjamin Enns, Linwei Wang, et al.
Plos Medicine|September 28, 2011
Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in HaitiSerena P Koenig, Heejung Bang, Patrice Severe, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|September 12, 2017
When "the Cure" Is the Risk: Understanding How Substance Use Affects HIV and HCV in a Layered Risk Environment in San Juan, Puerto RicoDiana Hernández, Pedro C Castellón, Yohansa Fernández, et al.
Health & Justice|September 23, 2018
Criminal justice measures for economic data harmonization in substance use disorder researchKathryn E McCollister, Xuan Yang, Sean M Murphy, et al.
Medical Care|February 25, 2015
The lifetime medical cost savings from preventing HIV in the United StatesBruce R Schackman, John A Fleishman, Amanda E Su, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|April 7, 2007
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppressionRoy M Gulick, Christina M Lalama, Heather J Ribaudo, et al.
AIDS and Behavior|August 23, 2025
FANMI ("My Family"): A Randomized Trial of Community Cohort Care for Adolescent Girls and Young Women Living with HIV in HaitiVanessa Rouzier, Lindsey K Reif, Rose Cardelle Riche, et al.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
AIDS and Behavior|August 18, 2025
Comparing Implementation and Effectiveness Outcomes for Two Implementation Strategies of the Keep It Up! Digital HIV Prevention Program: A Type 3 Hybrid Effectiveness-Implementation TrialBrian Mustanski, Nanette Benbow, Kathryn Macapagal, et al.
Drug and Alcohol Dependence|January 18, 2022
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugsSarah Gutkind, Laura E Starbird, Sean M Murphy, et al.
Plos One|May 31, 2019
Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesisEmanuel Krebs, Benjamin Enns, Linwei Wang, et al.
Plos Medicine|September 28, 2011
Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in HaitiSerena P Koenig, Heejung Bang, Patrice Severe, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|September 12, 2017
When "the Cure" Is the Risk: Understanding How Substance Use Affects HIV and HCV in a Layered Risk Environment in San Juan, Puerto RicoDiana Hernández, Pedro C Castellón, Yohansa Fernández, et al.
Health & Justice|September 23, 2018
Criminal justice measures for economic data harmonization in substance use disorder researchKathryn E McCollister, Xuan Yang, Sean M Murphy, et al.
Medical Care|February 25, 2015
The lifetime medical cost savings from preventing HIV in the United StatesBruce R Schackman, John A Fleishman, Amanda E Su, et al.
Pageof 23